Researchers have identified 10 genetic mutations that can predict the most common type of bladder cancer up to 12 years prior to diagnosis. The study results were presented at the European Association ...

Testing for genetic mutations in urine can detect bladder cancer years before the disease shows clinical symptoms, new research has shown. The study, by researchers from France, Iran and the United ...

Bladder cancer is common, and the diagnosis can often be invasive In a recent study, detecting genetic alterations in urine could help diagnose bladder cancer years before symptoms appear The test ...

You’d think you’d look for signs of bladder cancer in urine, wouldn’t you? Sadly, it’s easier said than done, so there’s normally a need for uncomfortable and invasive cystoscopy exams, with a camera ...

Lead investigators Sungwhan An, PhD, CEO and Scientific Director, Genomictree, Inc., Daejeon, South Korea, and Ju Hyun Shin, MD, Department of Urology, Chungnam ...

SOUTH SAN FRANCISCO, Calif., February 05, 2025--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data that reinforce the ability of its ...

Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.

The Decipher Bladder test identifies aggressive bladder cancer, aiding in treatment decisions beyond initial clinical staging. Non-luminal tumors in NMIBC show higher upstaging rates to MIBC and ...

A novel approach to the treatment of high-risk non–muscle-invasive bladder cancer: Combining immune checkpoint inhibitor (ICI) and microtubule inhibitor (MTI). This is an ASCO Meeting Abstract from ...

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been added to ResearchAndMarkets.com's ...